EBV-specific T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-specific T lymphocytes, covering 2025-12-12 to 2025-12-12. Get the full timeline:
Most recent: Clinical Trial Update: EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma [Phase 1]